Author

Holly S. Geres

Observed names: Holly Geres, Holly S Geres

Institutions: Duke University, Duke Medical Center

Observed institutions: Duke University, Duke Medical Center

OpenAlex ID: A5045925121

Safety and microbiological activity of phage therapy in persons with cystic fibrosis colonized with Pseudomonas aeruginosa: study protocol for a phase 1b/2, multicenter, randomized, double-blind, placebo-controlled trial

2022 · Pranita D. Tamma, Maria Souli, et al. · Trials · 66

Moving Beyond Mortality: Development and Application of a Desirability of Outcome Ranking (DOOR) Endpoint for Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia

2023 · Jessica Howard-Anderson, Toshimitsu Hamasaki, et al. · Clinical Infectious Diseases · 18

The Future Ain’t What It Used to Be…Out With the Old…In With the Better: Antibacterial Resistance Leadership Group Innovations

2023 · Scott R Evans, Robin Patel, et al. · Clinical Infectious Diseases · 13

The Antibacterial Resistance Leadership Group: Scientific Advancements and Future Directions

2023 · Henry F Chambers, Heather R Cross, et al. · Clinical Infectious Diseases · 10

Fast Antimicrobial Susceptibility Testing for Gram-Negative Bacteremia

2026 · Ritu Banerjee, Lauren Komarow, et al. · JAMA · 7

Priorities and Progress in Gram-positive Bacterial Infection Research by the Antibacterial Resistance Leadership Group: A Narrative Review

2023 · Sarah B Doernberg, Cesar A Arias, et al. · Clinical Infectious Diseases · 6

Study protocol for a multicenter, multinational prospective randomized controlled trial comparing outcomes in subjects with Gram-negative bacteremia who have blood culture evaluation using Fast Antibiotic Susceptibility Testing vs. standard of care testing: the FAST trial

2025 · Ritu Banerjee, Lauren Komarow, et al. · Trials · 3

Development and Application of a Desirability of Outcome Ranking (DOOR) Endpoint for Acute Bacterial Skin and Skin Structure Infections

2026 · Jessica Howard-Anderson, Toshimitsu Hamasaki, et al. · Open Forum Infectious Diseases · 2

84. Improving Traditional Registrational Trial Endpoints: Development and Application of a Desirability of Outcome Ranking (DOOR) Endpoint for Acute Bacterial Skin and Skin-Structure Infections

2025 · Jessica Howard-Anderson, Toshimitsu Hamasaki, et al. · Open Forum Infectious Diseases · 2

Under the Hood: The Scientific Leadership, Clinical Operations, Statistical and Data Management, and Laboratory Centers of the Antibacterial Resistance Leadership Group

2023 · Heather R Cross, Kerryl E Greenwood-Quaintance, et al. · Clinical Infectious Diseases · 2

Works count: 10

Citation count: 129

H-index: 6

I10-index: 4